Parikh Family Office

Parikh Family Office

Nihar Parikh established the Parikh Family Office after leading the turnaround of ZCL Chemicals, a company the family reacquired in 2008. The wealth originated in Zandu Pharmaceuticals, an established Indian healthcare business. The office operates through its 4point0 platform with a primary focus on healthcare. The strategy centers on direct co-investments and SPVs in healthtech. Confirmed positions include Qure.ai, an AI radiology platform, OneSource, a CDMO business, and Medvital, a medical consumables provider. The firm also backs an unnamed leading IVF operator in South India. Activity remains concentrated in Asia with an emphasis on India. Investments target seed through Series B stages and combine capital with sector operating input. No public data exists on total professionals or additional offices. The $75 million healthtech vehicle launched in August 2022. The office maintains no disclosed philanthropic vehicles or club memberships. The structural feature is the direct link between the family’s prior operating ownership of pharmaceutical manufacturing assets and current venture deployment. This creates a sourcing and value-add model tied to the same sector rather than a pure financial allocation mandate.